The Boehringer Ingelheim Vetmedica, Inc. (BIVI) complete line of canine and feline vaccines is time-tested and proved safe and effective. They offer the latest vaccine technology with the most up-to-date protection against major dog and cat diseases. They are the most widely used vaccines in U.S. veterinary clinics today.
Founded in 1885, BIVI is a family-owned global company with 44,000 employees worldwide. The company has $1 billion in global animal health sales and ranks in the top five of all animal health companies. Boehringer Ingelheim focuses on human and animal health, and markets products in 152 countries with more than $17 billion net sales.
Research & Development
BIVI operates four cutting-edge vaccine research centers in St. Joseph in Missouri and Fort Dodge, Ames and Sioux City in Iowa. These centers are instrumental in innovative delivery technology.
BIVI works continuously to improve its world-class manufacturing process through technical expertise and state-of-the-art manufacturing practices. Biological production meets all global standards in manufacturing bacterial and viral vaccines, and produces more than 120 high-quality antigens places in innovative products for dogs, cats, pigs, cattle and horses. Currently BIVI produces over 800 million doses of vaccine per year and estimates the number of doses will increase to a billion by 2015. All BIVI pet vaccines are made with PureFilTM Technology, exemplifying our commitment to quality and continuous improvement. BIVI is committed to finding new and innovative methods to provide pet owners products that are safe and effective.
BIVI vaccines are the most widely used feline and canine vaccines in veterinary clinics today. Contact us to get more information regarding the full line of BIVI Fel-O-Vax and Fel-O-Guard feline vaccines, including kitten shots.